Literature DB >> 3892703

Central nervous system toxicity with high-dose cytosine arabinoside.

R H Herzig, H M Lazarus, G P Herzig, P F Coccia, S N Wolff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3892703

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  5 in total

Review 1.  High-dose cytosine arabinoside: pharmacological and clinical aspects.

Authors:  W G Peters; L P Colly; R Willemze
Journal:  Blut       Date:  1988-01

2.  Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukaemia.

Authors:  E Pääkkö; L Vainionpää; J Pyhtinen; M Lanning
Journal:  Neuroradiology       Date:  1996-04       Impact factor: 2.804

Review 3.  Current pharmacological treatment approaches to central nervous system leukaemia.

Authors:  S M Blaney; F M Balis; D G Poplack
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

4.  A phase II study of high-dose cytosine arabinoside in the treatment of acute leukaemia in adults.

Authors:  M J Barnett; A Z Rohatiner; T S Ganesan; M A Richards; A Miller; T A Lister
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity.

Authors:  L H Lindner; H Ostermann; W Hiddemann; A Kiani; M Würfel; T Illmer; C Karsch; U Platzbecker; G Ehninger; E Schleyer
Journal:  Int J Hematol       Date:  2008-10-04       Impact factor: 2.490
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.